The HMGB1/RAGE axis has been found to affect proliferation in cervical cancer, glioma, and clear cell carcinoma through the Mitogen-Activated Protein Kinase (MAPK) signaling pathway. Here, AGER is linked to clear cell adenocarcinoma.